FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772445760> ?p ?o ?g. }

• W2772445760 endingPage "1440" @default.
• W2772445760 startingPage "1429" @default.
• W2772445760 abstract "Yttrium‐90 transarterial radioembolization (TARE) is a locoregional therapy (LRT) for hepatocellular carcinoma (HCC). In this study, we present overall survival (OS) outcomes in a 1,000‐patient cohort acquired over a 15‐year period. Between December 1, 2003 and March 31, 2017, 1,000 patients with HCC were treated with TARE as part of a prospective cohort study. A comprehensive review of toxicity and survival outcomes was performed. Outcomes were stratified by baseline Child‐Pugh (CP) class, United Network for Organ Sharing (UNOS), and Barcelona Clinic Liver Cancer (BCLC) staging systems. Albumin and bilirubin laboratory toxicities were compared to baseline. OS outcomes were reported using censoring and intention‐to‐treat methodologies. All treatments were outpatient, with a median one treatment per patient. Five hundred six (51%) were CP A, 450 (45%) CP B, and 44 (4%) CP C. Two hundred sixty‐three (26%) patients were BCLC A, 152 (15%) B, 541 (54%) C, and 44 (4%) D. Three hundred sixty‐eight (37%) were UNOS T1/T2, 169 (17%) T3, 147 (15%) T4a, 223 (22%) T4b, and 93 (9%) N/M. In CP A patients, censored OS for BCLC A was 47.3 (confidence interval [CI], 39.5‐80.3) months, BCLC B 25.0 (CI, 17.3‐30.5) months, and BCLC C 15.0 (CI, 13.8‐17.7) months. In CP B patients, censored OS for BCLC A was 27 (CI, 21‐30.2) months, BCLC B 15.0 (CI, 12.3‐19.0) months, and BCLC C 8.0 (CI, 6.8‐9.5) months. Forty‐nine (5%) and 110 (11%) patients developed grade 3/4 albumin and bilirubin toxicities, respectively. Conclusion: Based on our experience with 1,000 patients over 15 years, we have made a decision to adopt TARE as the first‐line transarterial LRT for patients with HCC. Our decision was informed by prospective data and incrementally reported demonstrating outcomes stratified by BCLC, applied as either neoadjuvant or definitive treatment. (Hepatology 2017)." @default.
• W2772445760 created "2017-12-22" @default.
• W2772445760 creator A5003389418 @default.
• W2772445760 creator A5011003738 @default.
• W2772445760 creator A5028184921 @default.
• W2772445760 creator A5029706633 @default.
• W2772445760 creator A5030361802 @default.
• W2772445760 creator A5030666817 @default.
• W2772445760 creator A5033464248 @default.
• W2772445760 creator A5034174603 @default.
• W2772445760 creator A5034975837 @default.
• W2772445760 creator A5036972230 @default.
• W2772445760 creator A5040236972 @default.
• W2772445760 creator A5044862107 @default.
• W2772445760 creator A5047739800 @default.
• W2772445760 creator A5055996794 @default.
• W2772445760 creator A5060796651 @default.
• W2772445760 creator A5064049623 @default.
• W2772445760 creator A5064934106 @default.
• W2772445760 creator A5066524469 @default.
• W2772445760 creator A5071616102 @default.
• W2772445760 creator A5073037737 @default.
• W2772445760 creator A5073412832 @default.
• W2772445760 creator A5075153200 @default.
• W2772445760 creator A5082906150 @default.
• W2772445760 creator A5085978876 @default.
• W2772445760 creator A5086297355 @default.
• W2772445760 creator A5087536545 @default.
• W2772445760 creator A5090043054 @default.
• W2772445760 date "2018-01-29" @default.
• W2772445760 modified "2023-10-11" @default.
• W2772445760 title "Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience" @default.
• W2772445760 cites W1570173114 @default.
• W2772445760 cites W1633413258 @default.
• W2772445760 cites W1948056189 @default.
• W2772445760 cites W1971837077 @default.
• W2772445760 cites W1982200516 @default.
• W2772445760 cites W1984869178 @default.
• W2772445760 cites W1998417832 @default.
• W2772445760 cites W2022384547 @default.
• W2772445760 cites W2059377623 @default.
• W2772445760 cites W2071618269 @default.
• W2772445760 cites W2077014377 @default.
• W2772445760 cites W2089242758 @default.
• W2772445760 cites W2160554202 @default.
• W2772445760 cites W2163403599 @default.
• W2772445760 cites W2315239834 @default.
• W2772445760 cites W2322456755 @default.
• W2772445760 cites W2433187988 @default.
• W2772445760 cites W2509930573 @default.
• W2772445760 cites W2560499218 @default.
• W2772445760 cites W2581205085 @default.
• W2772445760 cites W2598806459 @default.
• W2772445760 cites W2613310948 @default.
• W2772445760 cites W2747090942 @default.
• W2772445760 cites W2752251204 @default.
• W2772445760 cites W2917837889 @default.
• W2772445760 cites W4245784696 @default.
• W2772445760 cites W4376595334 @default.
• W2772445760 doi "https://doi.org/10.1002/hep.29691" @default.
• W2772445760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29194711" @default.
• W2772445760 hasPublicationYear "2018" @default.
• W2772445760 type Work @default.
• W2772445760 sameAs 2772445760 @default.
• W2772445760 citedByCount "167" @default.
• W2772445760 countsByYear W27724457602018 @default.
• W2772445760 countsByYear W27724457602019 @default.
• W2772445760 countsByYear W27724457602020 @default.
• W2772445760 countsByYear W27724457602021 @default.
• W2772445760 countsByYear W27724457602022 @default.
• W2772445760 countsByYear W27724457602023 @default.
• W2772445760 crossrefType "journal-article" @default.
• W2772445760 hasAuthorship W2772445760A5003389418 @default.
• W2772445760 hasAuthorship W2772445760A5011003738 @default.
• W2772445760 hasAuthorship W2772445760A5028184921 @default.
• W2772445760 hasAuthorship W2772445760A5029706633 @default.
• W2772445760 hasAuthorship W2772445760A5030361802 @default.
• W2772445760 hasAuthorship W2772445760A5030666817 @default.
• W2772445760 hasAuthorship W2772445760A5033464248 @default.
• W2772445760 hasAuthorship W2772445760A5034174603 @default.
• W2772445760 hasAuthorship W2772445760A5034975837 @default.
• W2772445760 hasAuthorship W2772445760A5036972230 @default.
• W2772445760 hasAuthorship W2772445760A5040236972 @default.
• W2772445760 hasAuthorship W2772445760A5044862107 @default.
• W2772445760 hasAuthorship W2772445760A5047739800 @default.
• W2772445760 hasAuthorship W2772445760A5055996794 @default.
• W2772445760 hasAuthorship W2772445760A5060796651 @default.
• W2772445760 hasAuthorship W2772445760A5064049623 @default.
• W2772445760 hasAuthorship W2772445760A5064934106 @default.
• W2772445760 hasAuthorship W2772445760A5066524469 @default.
• W2772445760 hasAuthorship W2772445760A5071616102 @default.
• W2772445760 hasAuthorship W2772445760A5073037737 @default.
• W2772445760 hasAuthorship W2772445760A5073412832 @default.
• W2772445760 hasAuthorship W2772445760A5075153200 @default.
• W2772445760 hasAuthorship W2772445760A5082906150 @default.
• W2772445760 hasAuthorship W2772445760A5085978876 @default.
• W2772445760 hasAuthorship W2772445760A5086297355 @default.
• W2772445760 hasAuthorship W2772445760A5087536545 @default.

• next